YOLFTbeta
Lucid Diagnostics Inc

Lucid Diagnostics Inc

LUCD · NASDAQ · Healthcare / Medical Devices

0.4491USD+0.03 (+7.88%)

Price History

Full chart

Market Stats

Previous Close0.4163
Open0.4441
Day Range0.4226 – 0.4921
52-Week Range0.75 – 1.63
Volume3.46M
Market Cap157.72M
P/E (TTM)0.00
Forward P/E0.00
EPS-0.41
Dividend Yield0.00%
Beta1.10
50-Day Avg0.9257
200-Day Avg1.10

About

Lucid Diagnostics Inc. operates as a commercial-stage medical diagnostics technology company in the United States. It focuses on patients with gastroesophageal reflux disease (GERD) who are at risk of developing esophageal precancer and cancer, primarily highly lethal esophageal adenocarcinoma. The company's flagship product, the EsoGuard Esophageal DNA Test performed on samples collected with the EsoCheck Esophageal Cell collection device, a testing tool with the goal of preventing EAC deaths through early detection of esophageal precancer in at-risk GERD patients. The company was incorporated in 2018 and is based in New York, New York. Lucid Diagnostics Inc. operates as a subsidiary of PAVmed Inc.

Company Details

  • SectorHealthcare
  • IndustryMedical Devices
  • CEODr. Lishan Aklog M.D.
  • Employees82
  • Headquarters360 Madison Avenue, New York, NY, United States, 10017, USA
  • Websitehttps://www.luciddx.com

Leadership

  • Dr. Lishan Aklog M.D.Chairman & CEO · b. 1966
  • Mr. Shaun M. O'Neill M.B.A.President & COO · b. 1982
  • Mr. Dennis M. McGrath C.P.A.Chief Financial Officer · b. 1957
  • Mr. Michael Adam GordonGeneral Counsel & Secretary · b. 1975
  • Dr. Sanford D. Markowitz M.D., Ph.D.Co-Founder & Strategic Advisor
  • Dr. Joseph Willis M.D.Co-founder & Strategic Advisor
  • Dr. Amitabh Chak M.D.Co-Founder & Strategic Advisor
  • Helen Moinova Ph.D.Co-Founder & Strategic Advisor
  • Dr. Brian J. deGuzman M.D.Chief Technology & Compliance Officer · b. 1965
  • Dr. Suman M. Verma M.D., Ph.D.Senior VP & Chief Scientific Officer

Financials

Income Statement

Currency: USD2018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue-00500.00K377.00K2.43M4.35M4.71M
Growth (%)-----24.60%+544.03%+79.00%+8.28%
Cost of Revenue--0585.00K3.61M8.48M8.27M7.54M
Gross Profit--0-85.00K-3.24M-6.05M-3.92M-2.84M
Gross Margin----17.00%-858.62%-249.18%-90.20%-60.26%
Operating Expense--8.28M27.33M52.93M42.43M42.13M46.80M
Operating Income-1.13M-4.42M-8.28M-27.42M-56.17M-48.48M-46.05M-49.64M
Operating Margin----5483.80%-14899.47%-1996.79%-1059.64%-1054.82%
EBITDA562.96K-4.42M-8.28M-27.41M-54.23M-49.75M-44.34M-57.12M
EBITDA Margin----5483.00%-14383.82%-2049.05%-1020.16%-1213.68%
Net Income-1.13M-4.42M-8.28M-28.08M-56.17M-52.67M-45.53M-58.01M
Net Income Margin----5615.60%-14899.47%-2169.11%-1047.61%-1232.68%
R&D715.63K3.46M5.44M9.30M11.47M7.25M5.99M5.68B
R&D as % of Total Revenue---1859.20%3041.38%298.68%137.87%120654.48%
Interest Expense000659.00K8.00K416.00K26.00K22.00K
Interest Expense % of Total Revenue---131.80%2.12%17.13%0.60%0.47%

Balance Sheet

Currency: USD2018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets17.80K1.03M2.19M59.00M32.51M27.27M30.71M40.45M
Total Liabilities1.08M6.34M15.71M4.26M9.46M29.58M25.32M29.51M
Total Equity-1.06M-5.31M-13.52M54.74M23.05M-2.31M5.39M10.94M
Cash17.80K156.40K111.00K53.66M22.47M18.90M22.36M34.70M
Total Debt----2.00M15.26M21.25M25.82M
Net Debt-17.80K-156.40K-111.00K-53.66M-20.48M-3.64M-1.10M-8.88M

Cash Flow

Currency: USD2018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-170.55K-2.36M-5.63M-17.67M-29.68M-32.82M-44.14M-46.48M
Investing Cash Flow-862.00K-862.00K-862.00K-862.00K-4.11M-221.00K-646.00K-197.00K
Financing Cash Flow131.50K2.50M5.58M72.08M2.61M29.46M48.25M59.03M
Capital Expenditure862.00K4862.00K862.00K908.00K221.00K646.00K197.00K
Free Cash Flow-113.70K-2.36M-5.63M-18.53M-30.59M-33.04M-44.79M-46.48M
FCF to OCF66.67%100.00%100.00%104.88%103.06%100.67%101.46%100.00%

Earnings

Report DateDec 31, 2018Mar 31, 2020Jun 30, 2020Sep 30, 2020Dec 31, 2020Mar 31, 2021Jun 30, 2021Sep 1, 2021Nov 16, 2021Mar 28, 2022May 11, 2022Aug 15, 2022Nov 14, 2022Mar 13, 2023May 15, 2023Aug 14, 2023Nov 13, 2023Mar 25, 2024May 13, 2024Aug 12, 2024Nov 12, 2024Mar 24, 2025May 13, 2025Aug 12, 2025Nov 12, 2025Mar 30, 2026May 13, 2026Aug 13, 2026Nov 11, 2026
EPS Estimate0.000.000.000.000.000.000.00-0.34-0.23-0.20-0.24-0.28-0.32-0.38-0.30-0.27-0.22-0.20-0.27-0.18-0.18-0.17-0.11-0.10-0.09-0.10-0.06-0.05-0.05
EPS Actual-0.11-0.22-0.13-0.24-0.24-0.37-0.62-0.39-0.49-0.32-0.23-0.28-0.28-0.23-0.24-0.23-0.22-0.23-0.40-0.20-0.20-0.19-0.16-0.10-0.10-0.10-0.07-0.08-
Surprise--------14.71%-113.04%-60.00%4.17%0.00%12.50%39.47%20.00%14.81%0.00%-15.00%-48.15%-11.11%-11.11%-11.76%-45.45%0.00%-11.11%-2.56%-16.67%-60.00%-
Timing--------After-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketPre-marketAfter-hours-After-hoursAfter-hoursPre-market-After-hoursPre-marketPre-market

Key Statistics & Ratios

Market Cap157.72M
Enterprise Value152.02M
Trailing P/E0.00
Forward P/E0.00
Price / Sales28.97
Price / Book14.69
EPS-0.41
Book Value0.057
Revenue (TTM)5.45M
Gross Profit (TTM)-1.18M
EBITDA-49.81M
Profit Margin0.00%
Operating Margin-868.45%
Return on Equity-556.27%
Return on Assets-81.63%
Shares Outstanding190.95M
Shares Float140.76M
Beta1.10
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Analyst Ratings

Strong Buy
Based on 6 analystsTarget 4.00
  • Strong Buy
    4
  • Buy
    2

Ownership Breakdown

Institutions
33.37%
Insiders
26.50%
Retail / Other
40.13%

Top Institutional Holders

  • BlackRock Inc
    4.64M2.43%
  • Vanguard Capital Management, LLC
    4.15M2.18%
  • Masters Capital Management LLC
    4.00M2.09%
  • Aberdeen Group PLC
    3.82M2.00%
  • Two Seas Capital LP
    3.00M1.57%
  • Geode Capital Management, LLC
    2.25M1.18%
  • State Street Corp
    1.55M0.81%
  • Wells Fargo & Co
    1.27M0.67%
  • Perkins Capital Management Inc
    1.13M0.59%
  • Sunbelt Securities
    900.01K0.47%
  • Northern Trust Corp
    670.59K0.35%
  • Vanguard Fiduciary Trust Co
    623.56K0.33%
  • Vanguard Portfolio Management, LLC
    528.77K0.28%

Top Fund Holders

  • Vanguard MStar Total Stk Mkt Idx Invest
    4.55M2.38%
  • abrdn Healthcare Opportunities
    4.42M2.31%
  • iShares Russell 2000 ETF
    3.51M1.84%
  • Fidelity Small Cap Index
    1.58M0.83%
  • iShares Russell 2000 Growth ETF
    1.41M0.74%
  • Vanguard Russell 2000 ETF
    851.88K0.45%
  • Fidelity Extended Market Index
    790.27K0.41%